Wedbush Starts Caliper Life Sciences (CALP)at Outperform; CALPe Diem: Seize the Opportunity - Under-the-Radar Fast Growing Tools Player
Tweet Send to a Friend
Wedbush initiates coverage on Caliper Life Sciences (NASDAQ: CALP) with a Outperform. PT $9.
Wedbush analyst says, "Robust imaging tools ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "Robust imaging tools ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
